Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2024 · 10-Q
Revenue$10.02M$10.02M+10.7% vs Q3 2023 Net Income-$1.61M-$1.61MN/M vs Q3 2023 EPS Diluted-$0.52-$0.52N/M vs Q3 2023 Operating Income-$1,171,763N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,227,018N/M Margins · derivedOperating margin-11.7%+15.0 pt vs Q3 2023
Net margin-16.0%+9.0 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end